Other Species / Isoforms
  SUGT1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T8-p
MAAAAAGtATsQRFF
0 1
SUGT1 (human) MAAAAAGtATsQRFF T8-p
SUGT1 iso2 (human) MAAAAAGTATSQRFF T8
SUGT1 (mouse) MAAAAAGPASSQRLF P8
SUGT1 (rat) MAAAAAGPASSQRFF P8
S11-p
AAAGtATsQRFFQsF
0 2
SUGT1 (human) AAAGtATsQRFFQsF S11-p
SUGT1 iso2 (human) AAAGTATSQRFFQSF S11
SUGT1 (mouse) AAAGPASSQRLFQSF S11
SUGT1 (rat) AAAGPASSQRFFQSF S11
S17-p
TsQRFFQsFsDALID
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • cell cycle regulation
Phosphatases, in vitro:
  • PHLPP (human)
Putative upstream phosphatases:
  • PHLPP (human)
SUGT1 (human) TsQRFFQsFsDALID S17-p
SUGT1 iso2 (human) TSQRFFQSFSDALID S17
SUGT1 (mouse) SSQRLFQSFSDALID S17
SUGT1 (rat) SSQRFFQSFPDALID S17
S19-p
QRFFQsFsDALIDED
0 3
SUGT1 (human) QRFFQsFsDALIDED S19-p
SUGT1 iso2 (human) QRFFQSFSDALIDED S19
SUGT1 (mouse) QRLFQSFSDALIDGD S19
SUGT1 (rat) QRFFQSFPDALIDGD P19
K41-ub
LTKALEQkPDDAQyy
0 2
SUGT1 (human) LTKALEQkPDDAQyy K41-ub
SUGT1 iso2 (human) LTKALEQKPDDAQYY K41
SUGT1 (mouse) LTKALEQNPDDAQyY N41
SUGT1 (rat) LTKALEQNPDDAQYY N41
Y47-p
QkPDDAQyyCQRAYC
0 63
SUGT1 (human) QkPDDAQyyCQRAYC Y47-p
SUGT1 iso2 (human) QKPDDAQYYCQRAYC Y47
SUGT1 (mouse) QNPDDAQyYCQRAYC Y47-p
SUGT1 (rat) QNPDDAQYYCQRAYC Y47
Y48-p
kPDDAQyyCQRAYCH
0 1
SUGT1 (human) kPDDAQyyCQRAYCH Y48-p
SUGT1 iso2 (human) KPDDAQYYCQRAYCH Y48
SUGT1 (mouse) NPDDAQyYCQRAYCH Y48
SUGT1 (rat) NPDDAQYYCQRAYCH Y48
K70-ub
VAVADAKkSLELNPN
0 2
SUGT1 (human) VAVADAKkSLELNPN K70-ub
SUGT1 iso2 (human) VAVADAKKSLELNPN K70
SUGT1 (mouse) DGIADVKKSLELNPN K70
SUGT1 (rat) DGIADVKKSLELNPN K70
K85-ub
NSTAMLRkGICEYHE
0 1
SUGT1 (human) NSTAMLRkGICEYHE K85-ub
SUGT1 iso2 (human) NSTAMLRKGICEYHE K85
SUGT1 (mouse) NCTALLRKGICEYHE K85
SUGT1 (rat) NSTALLRKGICEYYE K85
K93-ub
GICEYHEkNyAAALE
0 1
SUGT1 (human) GICEYHEkNyAAALE K93-ub
SUGT1 iso2 (human) GICEYHEKNYAAALE K93
SUGT1 (mouse) GICEYHEKDYASALE K93
SUGT1 (rat) GICEYYEKDYASALE K93
Y95-p
CEYHEkNyAAALETF
Upstream
0 2
Treatment
  • dasatinib
SUGT1 (human) CEYHEkNyAAALETF Y95-p
SUGT1 iso2 (human) CEYHEKNYAAALETF Y95
SUGT1 (mouse) CEYHEKDYASALETF Y95
SUGT1 (rat) CEYYEKDYASALETF Y95
S161
CQEAQNGSESEVWTH
0 1
SUGT1 (human) CQEAQNGSESEVWTH S161
SUGT1 iso2 (human) CQEAQNGSESEVWTH S129
SUGT1 (mouse) CQEIQNGsESEVSAS S129-p
SUGT1 (rat) CQEIQNGSEPEVSAS S129
K171-ub
EVWTHQSkIKYDWYQ
0 1
SUGT1 (human) EVWTHQSkIKYDWYQ K171-ub
SUGT1 iso2 (human) EVWTHQSKIKYDWYQ K139
SUGT1 (mouse) ASQRTQSKIKYDWYQ K142
SUGT1 (rat) ASQRTQSKIKYDWYQ K142
K194-ub
LMIKNVQkNDVNVEF
0 1
SUGT1 (human) LMIKNVQkNDVNVEF K194-ub
SUGT1 iso2 (human) LMIKNVQKNDVNVEF K162
SUGT1 (mouse) LMIKSVQKNDVRVGF K165
SUGT1 (rat) LMIKNVQKNDVRVDF K165
K204-ub
VNVEFSEkELSALVk
0 1
SUGT1 (human) VNVEFSEkELSALVk K204-ub
SUGT1 iso2 (human) VNVEFSEKELSALVK K172
SUGT1 (mouse) VRVGFSERELSALVK R175
SUGT1 (rat) VRVDFSEKELSAVVK K175
K211-ub
kELSALVkLPSGEDY
0 1
SUGT1 (human) kELSALVkLPSGEDY K211-ub
SUGT1 iso2 (human) KELSALVKLPSGEDY K179
SUGT1 (mouse) RELSALVKIPAGEDY K182
SUGT1 (rat) KELSAVVKIPSGEDC K182
K221-ub
SGEDYNLkLELLHPI
0 1
SUGT1 (human) SGEDYNLkLELLHPI K221-ub
SUGT1 iso2 (human) SGEDYNLKLELLHPI K189
SUGT1 (mouse) AGEDYSLKLRLLHPI K192
SUGT1 (rat) SGEDCSLKLRLLHPI K192
K241
TFKVLSTKIEIKLKK
0 1
SUGT1 (human) TFKVLSTKIEIKLKK K241
SUGT1 iso2 (human) TFKVLSTKIEIKLKK K209
SUGT1 (mouse) TFKVLSTKIEIKMKK K212
SUGT1 (rat) TFKVLSTkIEIKMKK K212-ac
K256-ub
PEAVRWEkLEGQGDV
0 2
SUGT1 (human) PEAVRWEkLEGQGDV K256-ub
SUGT1 iso2 (human) PEAVRWEKLEGQGDV K224
SUGT1 (mouse) PEAVRWEKLEGQGDE K227
SUGT1 (rat) PEAVRWEKLEGQGDV K227
T265-p
EGQGDVPtPkQFVAD
Upstream
Downstream
1 38
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • cell cycle regulation
Phosphatases, in vitro:
  • PHLPP (human)
Putative upstream phosphatases:
  • PHLPP (human)
Treatment
  • ischemia
  • nocodazole
  • selumetinib
  • vemurafenib
view more >
SUGT1 (human) EGQGDVPtPkQFVAD T265-p
SUGT1 iso2 (human) EGQGDVPTPKQFVAD T233
SUGT1 (mouse) EGQGDEPTPKQFTAD T236
SUGT1 (rat) EGQGDVPAPKQFTAD A236
K267-ub
QGDVPtPkQFVADVk
0 2
SUGT1 (human) QGDVPtPkQFVADVk K267-ub
SUGT1 iso2 (human) QGDVPTPKQFVADVK K235
SUGT1 (mouse) QGDEPTPKQFTADVK K238
SUGT1 (rat) QGDVPAPKQFTADVk K238
K274
kQFVADVKNLyPsSs
0 1
SUGT1 (human) kQFVADVKNLyPsSs K274
SUGT1 iso2 (human) KQFVADVKNLYPSSS K242
SUGT1 (mouse) KQFTADVKNMYPSSS K245
SUGT1 (rat) KQFTADVkNMYPSSS K245-ac
K274-ub
kQFVADVkNLyPsSs
0 4
SUGT1 (human) kQFVADVkNLyPsSs K274-ub
SUGT1 iso2 (human) KQFVADVKNLYPSSS K242
SUGT1 (mouse) KQFTADVKNMYPSSS K245
SUGT1 (rat) KQFTADVKNMYPSSS K245
Y277-p
VADVkNLyPsSsPyt
0 59
SUGT1 (human) VADVkNLyPsSsPyt Y277-p
SUGT1 iso2 (human) VADVKNLYPSSSPYT Y245
SUGT1 (mouse) TADVKNMYPSSSHYT Y248
SUGT1 (rat) TADVkNMYPSSSHYT Y248
S279-p
DVkNLyPsSsPytRN
0 1
SUGT1 (human) DVkNLyPsSsPytRN S279-p
SUGT1 iso2 (human) DVKNLYPSSSPYTRN S247
SUGT1 (mouse) DVKNMYPSSSHYTRN S250
SUGT1 (rat) DVkNMYPSSSHYTRN S250
S281-p
kNLyPsSsPytRNWD
Upstream
Downstream
2 12
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • cell cycle regulation
Putative upstream phosphatases:
  • PHLPP (human)
SUGT1 (human) kNLyPsSsPytRNWD S281-p
SUGT1 iso2 (human) KNLYPSSSPYTRNWD S249
SUGT1 (mouse) KNMYPSSSHYTRNWD S252
SUGT1 (rat) kNMYPSSSHYTRNWD S252
Y283-p
LyPsSsPytRNWDkL
0 31
SUGT1 (human) LyPsSsPytRNWDkL Y283-p
SUGT1 iso2 (human) LYPSSSPYTRNWDKL Y251
SUGT1 (mouse) MYPSSSHYTRNWDKL Y254
SUGT1 (rat) MYPSSSHYTRNWDKL Y254
T284-p
yPsSsPytRNWDkLV
0 7
SUGT1 (human) yPsSsPytRNWDkLV T284-p
SUGT1 iso2 (human) YPSSSPYTRNWDKLV T252
SUGT1 (mouse) YPSSSHYTRNWDKLV T255
SUGT1 (rat) YPSSSHYTRNWDKLV T255
K289-ub
PytRNWDkLVGEIkE
0 1
SUGT1 (human) PytRNWDkLVGEIkE K289-ub
SUGT1 iso2 (human) PYTRNWDKLVGEIKE K257
SUGT1 (mouse) HYTRNWDKLVGEIKE K260
SUGT1 (rat) HYTRNWDKLVGEIKE K260
K295-sm
DkLVGEIkEEEkNEk
0 2
SUGT1 (human) DkLVGEIkEEEkNEk K295-sm
SUGT1 iso2 (human) DKLVGEIKEEEKNEK K263
SUGT1 (mouse) DKLVGEIKEEEkNEk K266
SUGT1 (rat) DKLVGEIKEEEKNEK K266
K299
GEIkEEEKNEkLEGD
0 1
SUGT1 (human) GEIkEEEKNEkLEGD K299
SUGT1 iso2 (human) GEIKEEEKNEKLEGD K267
SUGT1 (mouse) GEIKEEEkNEkLEGD K270-ac
SUGT1 (rat) GEIKEEEKNEKLEGD K270
K299-ub
GEIkEEEkNEkLEGD
0 1
SUGT1 (human) GEIkEEEkNEkLEGD K299-ub
SUGT1 iso2 (human) GEIKEEEKNEKLEGD K267
SUGT1 (mouse) GEIKEEEKNEkLEGD K270
SUGT1 (rat) GEIKEEEKNEKLEGD K270
K302-ub
kEEEkNEkLEGDAAL
0 3
SUGT1 (human) kEEEkNEkLEGDAAL K302-ub
SUGT1 iso2 (human) KEEEKNEKLEGDAAL K270
SUGT1 (mouse) KEEEkNEkLEGDAAL K273-ub
SUGT1 (rat) KEEEKNEKLEGDAAL K273
Y317-p
NRLFQQIysDGsDEV
Upstream
0 396
Regulatory protein:
  • FGFR1 (human)
Treatment
  • ephrin_B1
  • FGF2
  • U0126
view more >
SUGT1 (human) NRLFQQIysDGsDEV Y317-p
SUGT1 iso2 (human) NRLFQQIYSDGSDEV Y285
SUGT1 (mouse) NKLFQQIySDGsDEV Y288-p
SUGT1 (rat) NKLFQQIySDGSDEV Y288-p
S318-p
RLFQQIysDGsDEVk
Upstream
1 135
Phosphatases, in vitro:
  • PHLPP (human)
SUGT1 (human) RLFQQIysDGsDEVk S318-p
SUGT1 iso2 (human) RLFQQIYSDGSDEVK S286
SUGT1 (mouse) KLFQQIySDGsDEVK S289
SUGT1 (rat) KLFQQIySDGSDEVK S289
S321-p
QQIysDGsDEVkRAM
Upstream
Downstream
1 11
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • cell cycle regulation
Phosphatases, in vitro:
  • PHLPP (human)
Putative upstream phosphatases:
  • PHLPP (human)
SUGT1 (human) QQIysDGsDEVkRAM S321-p
SUGT1 iso2 (human) QQIYSDGSDEVKRAM S289
SUGT1 (mouse) QQIySDGsDEVKRAM S292-p
SUGT1 (rat) QQIySDGSDEVKRAM S292
K325-ub
sDGsDEVkRAMNksF
0 7
SUGT1 (human) sDGsDEVkRAMNksF K325-ub
SUGT1 iso2 (human) SDGSDEVKRAMNKSF K293
SUGT1 (mouse) SDGsDEVKRAMNKsF K296
SUGT1 (rat) SDGSDEVKRAMNKSF K296
K330-ub
EVkRAMNksFMEsGG
0 1
SUGT1 (human) EVkRAMNksFMEsGG K330-ub
SUGT1 iso2 (human) EVKRAMNKSFMESGG K298
SUGT1 (mouse) EVKRAMNKsFMESGG K301
SUGT1 (rat) EVKRAMNKSFMESGG K301
S331-p
VkRAMNksFMEsGGt
Upstream
Downstream
2 8
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Kinase, in vitro:
  • PLK1 (human)
Treatment
  • AZD1152
  • nocodazole
  • ZM447439
view more >
SUGT1 (human) VkRAMNksFMEsGGt S331-p
SUGT1 iso2 (human) VKRAMNKSFMESGGT S299
SUGT1 (mouse) VKRAMNKsFMESGGT S302-p
SUGT1 (rat) VKRAMNKSFMESGGT S302
S335-p
MNksFMEsGGtVLST
0 1
SUGT1 (human) MNksFMEsGGtVLST S335-p
SUGT1 iso2 (human) MNKSFMESGGTVLST S303
SUGT1 (mouse) MNKsFMESGGTVLST S306
SUGT1 (rat) MNKSFMESGGTVLST S306
T338-p
sFMEsGGtVLSTNWs
0 1
SUGT1 (human) sFMEsGGtVLSTNWs T338-p
SUGT1 iso2 (human) SFMESGGTVLSTNWS T306
SUGT1 (mouse) sFMESGGTVLSTNWS T309
SUGT1 (rat) SFMESGGTVLSTNWS T309
S345-p
tVLSTNWsDVGkRkV
0 2
SUGT1 (human) tVLSTNWsDVGkRkV S345-p
SUGT1 iso2 (human) TVLSTNWSDVGKRKV S313
SUGT1 (mouse) TVLSTNWSDVGKRKV S316
SUGT1 (rat) TVLSTNWSDVGKRKV S316
K349-ub
TNWsDVGkRkVEINP
0 2
SUGT1 (human) TNWsDVGkRkVEINP K349-ub
SUGT1 iso2 (human) TNWSDVGKRKVEINP K317
SUGT1 (mouse) TNWSDVGKRKVEINP K320
SUGT1 (rat) TNWSDVGKRKVEINP K320
K351-ub
WsDVGkRkVEINPPD
0 1
SUGT1 (human) WsDVGkRkVEINPPD K351-ub
SUGT1 iso2 (human) WSDVGKRKVEINPPD K319
SUGT1 (mouse) WSDVGKRKVEINPPD K322
SUGT1 (rat) WSDVGKRKVEINPPD K322
Y365-p
DDMEWKKy_______
0 51
SUGT1 (human) DDMEWKKy_______ Y365-p
SUGT1 iso2 (human) DDMEWKKY_______ Y333
SUGT1 (mouse) DDMEWKQY_______ Y336
SUGT1 (rat) DDMEWKQY_______ Y336